GILEAD SCIENCES, INC. EPS (Basic) 2007-2026 | GILD
Beta
What is eps (basic)?
Basic earnings per share (EPS) can be defined as net income divided by the weighted average number of common shares outstanding during a period.
What is GILEAD SCIENCES, INC.'s current eps (basic)?
GILEAD SCIENCES, INC. (GILD) annual eps (basic) for 2025 was $6.84, a 1700.00% increase from 2024. GILEAD SCIENCES, INC. eps (basic) for the quarter ending March 31, 2026 was $1.63.
What was GILEAD SCIENCES, INC.'s eps (basic) in 2024?
GILEAD SCIENCES, INC. annual eps (basic) for 2024 was $0.38, a 91.63% decline from 2023.
What was GILEAD SCIENCES, INC.'s eps (basic) in 2023?
GILEAD SCIENCES, INC. annual eps (basic) for 2023 was $4.54, a 24.04% increase from 2022.
What is GILEAD SCIENCES, INC.'s 5-year eps (basic) CAGR?
GILEAD SCIENCES, INC. eps (basic) grew at a compound annual growth rate (CAGR) of 132.82% from FY2020 to FY2025, going from $0.10 to $6.84 over 5 years.
EPS (Basic) History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+132.8%
FY2020
$0.10
→
FY2025
$6.84
07080910111213141516171819202122232425
5 years selected
EPS (Basic) History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $6.84 | +1700.0% | 10-K |
| FY2024 | $0.38 | -91.6% | 10-K |
| FY2023 | $4.54 | +24.0% | 10-K |
| FY2022 | $3.66 | -26.2% | 10-K |
| FY2021 | $4.96 | +4860.0% | 10-K |
| FY2020 | $0.10 | -97.6% | 10-K |
| FY2019 | $4.24 | +1.0% | 10-K |
| FY2018 | $4.20 | +18.6% | 10-K |
| FY2017 | $3.54 | -64.9% | 10-K |
| FY2016 | $10.08 | -18.5% | 10-K |
| FY2015 | $12.37 | +55.6% | 10-K |
| FY2014 | $7.95 | +295.5% | 10-K |
| FY2013 | $2.01 | +17.5% | 10-K |
| FY2012 | $1.71 | -5.5% | 10-K |
| FY2011 | $1.81 | +7.1% | 10-K |
| FY2010 | $1.69 | +16.2% | 10-K |
| FY2009 | $1.46 | +35.3% | 10-K |
| FY2008 | $1.07 | +25.7% | 10-K |
| FY2007 | $0.85 | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →